https://doi.org/10.4081/monaldi.2022.2418
Pulmonary embolism and gastric bleed with disseminated mucormycosis - treading dangerous waters
Submitted: August 30, 2022
Accepted: October 28, 2022
Published: November 25, 2022
Accepted: October 28, 2022
Abstract Views: 909
PDF: 143
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Mucormycosis is an opportunistic infection seen in immunocompromised patients or in surgical and trauma settings with Mucorales wound contamination. In immunocompetent people, disseminated mucormycosis is uncommon. To ensure survival, patients with mucormycosis require early diagnosis and aggressive treatment using a multi-modality approach. We present a case of disseminated mucormycosis in an immunocompetent patient who also had pulmonary embolism and gastrointestinal bleeding. A recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, identified retrospectively by a positive IgM against SARS-CoV-2, was the only risk factor present. This report emphasizes the increased risk of mucormycosis and thromboembolic complications following a recent SARS-CoV-2 infection, as well as its successful treatment with medical therapy alone.
Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005;18:556-69.
DOI: https://doi.org/10.1128/CMR.18.3.556-569.2005
Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: A Review of 929 reported cases. Clin Infect Dis 2005;1:634-53.
DOI: https://doi.org/10.1086/432579
Raut A, Huy NT. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Lancet Respir Med 2021;9:e77.
DOI: https://doi.org/10.1016/S2213-2600(21)00265-4
Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID- 19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021;15:102146.
DOI: https://doi.org/10.1016/j.dsx.2021.05.019
Tan BK, Mainbourg S, Friggeri A, et al. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax 2021;76:970-9.
DOI: https://doi.org/10.1136/thoraxjnl-2020-215383
Jacofsky D, Jacofsky EM, Jacofsky M. Understanding antibody testing for COVID-19. J Arthroplasty 2020;35:S74-S81.
DOI: https://doi.org/10.1016/j.arth.2020.04.055
Maraví-Poma E, Rodríguez-Tudela JL, de Jalón JG, et al. Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients. Intensive Care Med 2004;30:724-8.
DOI: https://doi.org/10.1007/s00134-003-2132-1
Pak J, Tucci VT, Vincent AL, et al. Mucormycosis in immunochallenged patients. J Emerg Trauma Shock 2008;1:106-13.
DOI: https://doi.org/10.4103/0974-2700.42203
Skiada A, Lass-Floerl C, Klimko N, et al. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol 20181;56:93-101.
DOI: https://doi.org/10.1093/mmy/myx101
Naqvi HA, Nadeem Yousaf M, Chaudhary FS, Mills L. Gastric mucormycosis: An infection of fungal invasion into the gastric mucosa in immunocompromised patients. Case Rep Gastrointest Med 2020;16:8876125.
DOI: https://doi.org/10.1155/2020/8876125
Chikley A, Ben-Ami R, Kontoyiannis DP. Mucormycosis of the central nervous system. J Fungi 2019;8:59.
DOI: https://doi.org/10.3390/jof5030059
Mignogna MD, Fortuna G, Leuci S, et al. Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature. Int J Infect Dis 2011;15:533-40.
DOI: https://doi.org/10.1016/j.ijid.2011.02.005
Nain PS, Matta H, Singh K, et al. Post-operative abdominal wall mucormycosis - a case series. Indian J Surg 2015;77:S253-6.
DOI: https://doi.org/10.1007/s12262-012-0786-z
How to Cite
Chauhan, Nishant Kumar, Ashish Agarwal, Naveen Dutt, Taruna Yadav, and Rishabh Kochar. 2022. “Pulmonary Embolism and Gastric Bleed With Disseminated Mucormycosis - Treading Dangerous Waters”. Monaldi Archives for Chest Disease 93 (3). https://doi.org/10.4081/monaldi.2022.2418.
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Fatemeh Khelghati, Fatemeh Nasirpour Seilakhori, Mehdi Goudarzi, Shima Malekloo, Amir Hashem Shahidi Bonjar, Hossein Goudarzi, Mohammad Javad Nasiri, Multidrug-resistant tuberculosis in Iran: a multicenter study , Monaldi Archives for Chest Disease: Early Access
- Biswajit Maharana , Pallab Chakraborty, Sudhan Rackimuthu , Rusab Baig, Shreeji Kadakia, Paradoxical role of oxygen in the treatment of patients with COVID-19 , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Josuel Ora, Angelo Coppola, Andrea Perduno, Gian Marco Manzetti, Ermanno Puxeddu, Paola Rogliani, Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Avneet Garg, Rakendra Singh, Hariharan Iyer, Mansimranjit Kaur, Surbhi Surbhi, Ashish Jindal, Saranpal Singh, Avtar Singh Bansal, Hem C. Sati, Vinita Jindal, To study heterogeneity in SARS-CoV-2 IgG response titre in patients recovered from COVID-19 , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Miguel Osejo-Betancourt, Sebastian Molina-Paez , Mariana Rubio-Romero , Pulmonary tuberculosis and COVID-19 coinfection: A new medical challenge , Monaldi Archives for Chest Disease: Vol. 92 No. 3 (2022)
- Afrah Alsomali, Abdullah Eltayeb, Sarah Aldosari, Maie AlShahid, Aly AlSanei, Ali AlEnazy, Olga Vriz, Recurrence of left ventricular pseudoaneurysm after multiple mitral valve replacements , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Nian Patel, Robert Nicolae, Georgios Geropoulos, Pallabhi Mandal, Chrysanthos D. Christou, Marianna Gavala, Nikolaos Madouros, Michail Papapanou, Rahul Mogal, Dimitrios Giannis, Konstantinos S. Kechagias, Nikolaos Panagiotopoulos, Pneumomediastinum in the COVID-19 era: to drain or not to drain? , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Laetitia Joërg, Tiffany Trouillon, Carole Jalaber, Isabelle Court Fortune, Antoine Luchez, Claire Boutet, Jean Michel Vergnon, Laurent Bertoletti, Marios E. Froudarakis, Chest ultrasound findings in usual interstitial pneumonia patterns: a pilot study , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Kenan Yalta, Ugur Ozkan, Tülin Yalta, Ertan Yetkin, Cardiac myxoma as a potential trigger of takotsubo cardiomyopathy: A brief review on mechanistic and clinical perspectives , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
- Kevin John, Ajay Kumar Mishra, Jemimah Nayar, Jordy Mehawej, Amos Lal, Coronavirus disease 2019 and mechanical circulatory support devices: a comprehensive review , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
<< < 75 76 77 78 79 80 81 > >>
You may also start an advanced similarity search for this article.
